'Lactate washout' following circulatory arrest.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 3392792)

Published in JAMA on August 05, 1988

Authors

J A Leavy1, M H Weil, E C Rackow

Author Affiliations

1: Department of Medicine, University of Health Sciences, Chicago Medical School, IL 60064.

Associated clinical trials:

Validity of Mini Fluid Challenge Post Liver Transplantation | NCT03396159

Articles by these authors

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA (1994) 5.24

Rapid enzymatic measurement of blood lactate and pyruvate. Use and significance of metaphosphoric acid as a common precipitant. Clin Chem (1967) 4.13

Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation (2003) 3.40

Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med (2000) 3.00

End-tidal carbon dioxide concentration during cardiopulmonary resuscitation. N Engl J Med (1988) 2.80

Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation (1970) 2.72

Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med (1983) 2.36

Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion presssure. JAMA (1991) 2.15

Gastric intramural PCO2 during peritonitis and shock. Chest (1993) 2.13

Temperature of the great toe as an indication of the severity of shock. Circulation (1969) 2.10

Airway protection during experimental CPR. Chest (1995) 1.96

Decreases in mortality on a large urban medical service by facilitating access to critical care. An alternative to rationing. Arch Intern Med (1988) 1.86

Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a task force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Writing Group. Circulation (1996) 1.84

Venous hypercarbia associated with severe sepsis and systemic hypoperfusion. Crit Care Med (1990) 1.74

Optimizing timing of ventricular defibrillation. Crit Care Med (2001) 1.74

Cardiac output and end-tidal carbon dioxide. Crit Care Med (1985) 1.71

Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation (1995) 1.68

Difference in acid-base state between venous and arterial blood during cardiopulmonary resuscitation. N Engl J Med (1986) 1.66

Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest (2000) 1.62

Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction. Crit Care Med (1988) 1.58

The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. J Am Coll Cardiol (1999) 1.50

Expired carbon dioxide: a noninvasive monitor of cardiopulmonary resuscitation. Circulation (1988) 1.50

Effect of crystalloid and colloid solutions on blood rheology in sepsis. Shock (1997) 1.48

Peripheral vascular tone in sepsis. Chest (1991) 1.47

Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation (1991) 1.46

Alterations in C3, C4, factor B, and related metabolites in septic shock. Clin Immunol Immunopathol (1993) 1.44

Increased venous-arterial carbon dioxide tension difference during severe sepsis in rats. Crit Care Med (1994) 1.44

Unaccounted for anion in metabolic acidosis during severe sepsis in humans. Crit Care Med (1991) 1.40

Competent and continuing care of the critically ill. Crit Care Med (1988) 1.39

The first decade of the American Board of Internal Medicine certification in critical care medicine: an overview of examinees and certificate holders from 1987 through 1996. Crit Care Med (2000) 1.38

Monophosphoryl lipid A attenuates the effects of endotoxic shock in pigs. J Lab Clin Med (1992) 1.38

Hypothermia after cardiac arrest. Crit Care Med (1991) 1.37

High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation (1997) 1.36

Septic shock. Lancet (1998) 1.26

Arteriovenous carbon dioxide and pH gradients during cardiac arrest. Circulation (1986) 1.24

Cardiac arrest in the critically ill. I. A study of predisposing causes in 132 patients. Circulation (1971) 1.22

Colloid oncotic pressure: clinical significance. Crit Care Med (1979) 1.20

Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med (2001) 1.19

Acute pulmonary edema in Plasmodium falciparum malaria. Am Rev Respir Dis (1978) 1.19

Hemodynamic and metabolic studies on shock associated with gram negative bacteremia. Medicine (Baltimore) (1973) 1.16

Electrical bioimpedance for noninvasive measurement of cardiac output. Crit Care Med (1997) 1.15

Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J Lab Clin Med (2000) 1.15

Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Resuscitation (1996) 1.15

Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock. Crit Care Med (1983) 1.14

Arterial PCO2 as an indicator of systemic perfusion during cardiopulmonary resuscitation. Crit Care Med (1989) 1.13

Proposed reclassification of shock states with special reference to distributive defects. Adv Exp Med Biol (1971) 1.12

Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood. Crit Care Med (1987) 1.12

Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med (1996) 1.12

Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest (1993) 1.12

Pulmonary edema related to changes in colloid osmotic and pulmonary artery wedge pressure in patients after acute myocardial infarction. Circulation (1975) 1.11

Redefining ischemia due to circulatory failure as dual defects of oxygen deficits and of carbon dioxide excesses. Crit Care Med (1991) 1.11

End-tidal CO2 as a guide to successful cardiopulmonary resuscitation: a preliminary report. Crit Care Med (1985) 1.11

Pulmonary edema during volume infusion. Circulation (1975) 1.11

Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation (1990) 1.10

Triage considerations in medical intensive care. Arch Intern Med (1990) 1.07

Quantitation of severity of critical illness with special reference to blood lactate. Crit Care Med (1974) 1.07

Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med (1995) 1.06

Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med (1998) 1.06

Cardiopulmonary resuscitation in the rat. J Appl Physiol (1985) (1988) 1.06

Pulmonary edema following intracranial hemorrhage. Chest (1979) 1.06

Cardiac arrest in the critically ill. II. Hyperosmolal states following cardiac arrest. Am J Med (1974) 1.04

Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock. J Appl Physiol (1985) (1998) 1.04

Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin: a prospective, double-blind, randomized, controlled trial. Crit Care Med (1995) 1.03

Ventricular fibrillation voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Lab Clin Med (1994) 1.01

Effects of hetastarch and albumin on coagulation in patients with septic shock. J Clin Pharmacol (1988) 1.01

Shock associated with barbiturate intoxication. JAMA (1971) 1.01

End-tidal carbon dioxide as a noninvasive indicator of cardiac index during circulatory shock. Crit Care Med (2000) 1.00

Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med (1987) 1.00

Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med (1993) 1.00

The relationship of the colloid osmotic-pulmonary artery wedge pressure gradient to pulmonary edema and mortality in critically ill patients. Chest (1982) 0.99

Cardiac output in bacterial shock. Am J Med (1978) 0.98

Selection of hemodynamic, respiratory and metabolic variables for evaluation of patients in shock. Crit Care Med (1975) 0.98

Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med (1994) 0.98

Routine plasma colloid osmotic pressure measurements. Crit Care Med (1975) 0.98

Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med (1967) 0.98

Adverse effects of interrupting precordial compression during cardiopulmonary resuscitation. Crit Care Med (1997) 0.97

New concepts in the diagnosis and fluid treatment of circulatory shock. Thirteenth annual Becton, Dickinson and Company Oscar Schwidetsky Memorial Lecture. Anesth Analg (1979) 0.97

Crystalloids, colloids, and fluid compartments. Crit Care Med (1999) 0.97

Unmeasured anion during severe sepsis with metabolic acidosis. Circ Shock (1990) 0.96

Myocardial acidosis associated with CO2 production during cardiac arrest and resuscitation. Circulation (1989) 0.96